Aileron Therapeutics Inc (ALRN)
NASDAQ:ALRN
Holding ALRN?
Track your performance easily

Aileron Therapeutics (ALRN) Financial Statements

1,197 Followers

Aileron Therapeutics Financial Overview

Aileron Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.247; its P/E ratio is -1.17; Aileron Therapeutics is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -8.94M$ -7.11M$ -7.30M$ -1.98M$ -1.79M
EBITDA$ -8.94M$ -7.05M$ -7.25M$ -1.97M$ -1.67M
Net Income Common Stockholders$ -8.94M$ -7.11M$ -7.34M$ -1.83M$ -1.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 21.92M$ 12.04M$ 17.31M$ 12.07M$ 13.67M
Total Assets$ 109.40M$ 99.19M$ 106.01M$ 12.82M$ 13.99M
Total Debt$ 0.00$ 0.00$ 48.00K$ 0.00$ 0.00
Net Debt$ -21.92M$ -12.04M$ -17.27M$ -12.07M$ -13.67M
Total Liabilities$ 8.38M$ 7.86M$ 7.71M$ 1.62M$ 1.20M
Stockholders Equity$ 56.02M$ 44.75M$ 6.89M$ 11.20M$ 12.79M
Cash Flow-
Free Cash Flow$ -8.39M$ -5.27M$ -10.39M$ -1.64M$ -3.12M
Operating Cash Flow$ -8.39M$ -5.27M$ -10.39M$ -1.64M$ -3.12M
Investing Cash Flow--$ -96.00K$ 542.00K$ 8.50M
Financing Cash Flow$ 18.26M-$ 15.79M--
Currency in USD

Aileron Therapeutics Earnings and Revenue History

Aileron Therapeutics Debt to Assets

Aileron Therapeutics Cash Flow

Aileron Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis